Oxford vaccine press info

• Techincal name is ChAdOx1
• ChAdOx1 is based on an adenovirus, which is another virus that causes mild upper respiratory tract infections
• Previously tested on flu, chikungunya, Zika and another coronavirus, Middle East Respiratory Syndrome (MERS).
• Testing for MERS completed a phase I clinical trial. It was safe and induced strong immune responses
• Phase II/III trial will enroll up to 10,260 adults and children across the UK.

link